Thx Pharma SA (ALTHX)

Currency in EUR
3.380
-0.060(-1.74%)
Closed·
ALTHX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.2603.440
52 wk Range
0.4305.100
Key Statistics
Prev. Close
3.38
Open
3.44
Day's Range
3.26-3.44
52 wk Range
0.43-5.1
Volume
101.53K
Average Volume (3m)
195.49K
1-Year Change
669.9317%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALTHX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.800
Upside
+71.60%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.800
(+71.60% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
24/09/2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
806.04K / --
EPS Revisions
Last 90 days

Compare ALTHX to Peers and Sector

Metrics to compare
ALTHX
Peers
Sector
Relationship
P/E Ratio
−15.5x−0.7x−0.5x
PEG Ratio
-0.100.00
Price/Book
-1.2x2.6x
Price / LTM Sales
57.4x3.5x3.3x
Upside (Analyst Target)
71.6%61.2%47.7%
Fair Value Upside
Unlock14.6%6.6%Unlock

THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
56.56K0.41%191.17K
Other Institutional Investors
1.85M13.44%6.27M
Public Companies & Retail Investors
11.89M86.15%40.17M
Total
13.8M100.00%46.63M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Beyond Batten Disease Foundation6.51%898,4373,037
Auriga Partners4.55%627,7622,122

People Also Watch

0.4040
ALSEN
+10.23%
1.0600
ALGID
-0.93%
4.755
MEMS
-10.11%
46.95
ALSEM
+11.79%
33.20
ALSOG
-1.19%

FAQ

What Is the Thx Pharma (Paris: ALTHX) Share Price Today?

The Thx Pharma stock price today is 3.380 EUR.

What Stock Exchange Does Thx Pharma (ALTHX) Trade On?

Thx Pharma is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Thx Pharma?

The stock symbol (also called a 'ticker') for Thx Pharma is "ALTHX."

What Is the Current Thx Pharma Market Capitalisation?

As of today, Thx Pharma (Paris: ALTHX) market cap is 46.630M EUR.

Is ALTHX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Thx Pharma moving averages and other technical indicators, the daily buy/sell signal for ALTHX stock is Neutral.

How Many Times Has Thx Pharma Stock Split?

Thx Pharma has split 0 times. (See the ALTHX stock split history page for full effective split date and price information.)

How Many Employees Does Thx Pharma Have?

Thx Pharma has 10 employees, based on their latest Companies House report.

What is the current trading status of Thx Pharma (Paris: ALTHX)?

As of 04/05/2026, Thx Pharma (ALTHX) is trading at a share price of 3.380 EUR, with a previous close of 3.380 EUR. The stock has fluctuated within a day range of 3.260 EUR to 3.440 EUR, while its 52-week range spans from 0.430 EUR to 5.100 EUR.

What Is Thx Pharma (ALTHX) Price Target According to Analysts?

The average 12-month price target for Thx Pharma is 5.800 EUR, with a high estimate of 5.8 EUR and a low estimate of 5.8 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +71.60% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.